CompuGroup Medical SE & Co. KGaA
CMPVFOTCHealthcare
$33.66
+$3.51(+11.64%)
Market Cap$1.7B
P/E Ratio—
52W High$33.66
52W Low$30.15
CompuGroup Medical SE & Co. KGaA (CMPVF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CMPVF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2025Report Date: Apr 30, 2025EPS Actual
$0.21
Est. $0.44 · -52.4%
Revenue
$0.29B
Est. $0.31B · -8.9%
Fiscal Period
Q2 FY2025
FY ends December
Report Date
Apr 30, 2025
After Market Close
▼ Miss EPS▼ Miss Revenue
CMPVF reports quarterly as a OTC-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Apr 28, 2026 | — | — | — | — | — | — |
| ◌ Q1 FY2026 | Mar 4, 2026 | — | — | — | — | — | — |
| ◌ Q4 FY2025 | Nov 5, 2025 | — | — | — | — | — | — |
| ◌ Q3 FY2025 | Jul 31, 2025 | $0.42 | — | — | — | $0.34B | — |
| ▼ Q2 FY2025 | Apr 30, 2025 | $0.44 | $0.21 | -52.4% | $0.29B | $0.31B | -8.9% |
| ▼ Q1 FY2025 | Mar 6, 2025 | $0.41 | -$0.13 | -130.6% | $0.31B | $0.33B | -6.4% |
| ▼ Q4 FY2024 | Nov 7, 2024 | $0.33 | $0.17 | -50.1% | $0.28B | $0.31B | -9.6% |
| ▼ Q3 FY2024 | Jul 15, 2024 | $0.54 | $0.27 | -49.8% | $0.30B | $0.33B | -9.4% |
Q2 FY2026
Apr 28, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 4, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 5, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Jul 31, 2025
EPS Actual
—
EPS Est.
$0.42
EPS Surpr.
—
Revenue
—
Q2 FY2025
Apr 30, 2025Miss
EPS Actual
$0.21
EPS Est.
$0.44
EPS Surpr.
-52.4%
Revenue
$0.29B
Q1 FY2025
Mar 6, 2025Miss
EPS Actual
-$0.13
EPS Est.
$0.41
EPS Surpr.
-130.6%
Revenue
$0.31B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
$0.17
EPS Est.
$0.33
EPS Surpr.
-50.1%
Revenue
$0.28B
Q3 FY2024
Jul 15, 2024Miss
EPS Actual
$0.27
EPS Est.
$0.54
EPS Surpr.
-49.8%
Revenue
$0.30B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2030 | $0.42 | $0.42 | $0.42 | 1 |
| Q1 FY2030 | $0.44 | $0.44 | $0.44 | 1 |
| Q4 FY2029 | $0.41 | $0.41 | $0.41 | 1 |
| Q3 FY2029 | $0.33 | $0.33 | $0.33 | 1 |
| Q2 FY2029 | $0.54 | $0.54 | $0.54 | 1 |
| Q1 FY2029 | $0.45 | $0.45 | $0.45 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2030 | $0.3B | $0.3B | $0.3B | 1 |
| Q1 FY2030 | $0.3B | $0.3B | $0.3B | 1 |
| Q4 FY2029 | $0.3B | $0.3B | $0.3B | 1 |
| Q3 FY2029 | $0.3B | $0.3B | $0.3B | 1 |
| Q2 FY2029 | $0.3B | $0.3B | $0.3B | 1 |
| Q1 FY2029 | $0.3B | $0.3B | $0.3B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2025 | Apr 30, 2025 | -52.4% | $23.85 | $23.85 | +0.00% |
| ▼ Q1 FY2025 | Mar 6, 2025 | -130.6% | $23.85 | $23.85 | +0.00% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -50.1% | $18.04 | $18.04 | +0.00% |
| ▼ Q3 FY2024 | Jul 15, 2024 | -49.8% | $18.04 | $18.04 | +0.00% |
| ▼ Q2 FY2024 | May 8, 2024 | -20.8% | $29.89 | $29.89 | +0.00% |
| ▼ Q1 FY2024 | Mar 28, 2024 | -260.2% | $29.89 | $29.89 | +0.00% |
| ▼ Q3 FY2023 | Sep 29, 2023 | -27.8% | $40.75 | $40.75 | +0.00% |
| ▲ Q2 FY2023 | Jun 29, 2023 | +2.2% | $34.00 | $34.00 | +0.00% |
Q2 FY2025+0.00%
Report Date
Apr 30, 2025
EPS Beat/Miss
-52.4%
Price Before
$23.85
Price After
$23.85
Q1 FY2025+0.00%
Report Date
Mar 6, 2025
EPS Beat/Miss
-130.6%
Price Before
$23.85
Price After
$23.85
Q4 FY2024+0.00%
Report Date
Nov 7, 2024
EPS Beat/Miss
-50.1%
Price Before
$18.04
Price After
$18.04
Q3 FY2024+0.00%
Report Date
Jul 15, 2024
EPS Beat/Miss
-49.8%
Price Before
$18.04
Price After
$18.04
Q2 FY2024+0.00%
Report Date
May 8, 2024
EPS Beat/Miss
-20.8%
Price Before
$29.89
Price After
$29.89
Q1 FY2024+0.00%
Report Date
Mar 28, 2024
EPS Beat/Miss
-260.2%
Price Before
$29.89
Price After
$29.89
Q3 FY2023+0.00%
Report Date
Sep 29, 2023
EPS Beat/Miss
-27.8%
Price Before
$40.75
Price After
$40.75
Q2 FY2023+0.00%
Report Date
Jun 29, 2023
EPS Beat/Miss
+2.2%
Price Before
$34.00
Price After
$34.00
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate1 / 8 quarters
Largest Move+0.00% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CMPVF ends December
CompuGroup Medical SE & Co. KGaA (CMPVF) most recently reported earnings on April 30, 2025 for Q2 FY2025, posting EPS of $0.21 — missing the analyst consensus of $0.44 by -52.4%. The next CMPVF earnings date is expected around September 1, 2026.
Each quarter, investors track CMPVF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CMPVF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CMPVF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CMPVF earnings · 5 questionsCompuGroup Medical SE & Co. KGaA's next earnings report is expected around September 1, 2026. CMPVF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CMPVF historically reports after market close (AMC).
CMPVF earnings datewhen is CMPVF earningsCMPVF next earnings datewhen does CMPVF report earningsCMPVF earnings calendar
▸ Source: FMP · CompuGroup Medical SE & Co. KGaA SEC filings · US GAAP · CompuGroup Medical SE & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026